Smart CPR

About

Value Proposition: Our automated mechanical chest compression device for cardiopulmonary resuscitation (‘SMART’ CPR) has the ability to improve patient outcomes from cardiac arrest by utilizing an adaptive, patient specific approach to CPR. This approach improves on the current technique of CPR where chest compressions are “fixed” at constant depth and rate. Our device adjusts depth and rate to adapt to the patient’s physiology such as chest size, blood perfusion signals, and cardiac arrest cause. Our animal studies have shown that ‘SMART’ CPR provides greater blood perfusion and leads to more favorable survival rates from cardiac arrest.   Market Opportunity: Our smart chest compression device would be available for use in ambulances and hospitals. There are over 300,000 out-of-hospital cardiac arrests in America every year where our device could be utilized. It would be placed in the~48,000 ambulances in the US, with the potential to expand to ~5,700 US hospitals and international markets. We also believe we could sell our device at a competitive price compared to automatic chest compression devices currently on the market.   Competitive Landscape: There are three main competitors: Zoll, Physio-Control, and Michigan Instruments. All of these devices give compressions at a fixed depth and rate regardless of patient chest size, cardiac arrest cause, or response to therapy. We expect our device to have a sizable advantage over the current market by integrating patient physiology with adaptive treatment.   Technology: There are three main competitors: Zoll, Physio-Control, and Michigan Instruments. All of these devices give compressions at a fixed depth and rate regardless of patient chest size, cardiac arrest cause, or response to therapy. We expect our device to have a sizable advantage over the current market by integrating patient physiology with adaptive treatment.